ClinicalTrials.gg
Sign In

Immunoglobulin G4-Related Disease clinical trials

The registry lists 72 studies for Immunoglobulin G4-Related Disease across more than 10 countries. 40 are recruiting or about to start. 53 of them are mainly about Immunoglobulin G4-Related Disease (how this is decided). Per ClinicalTrials.gov, last updated 2026-11-13.

Get an email when these change. Save the Immunoglobulin G4-Related Disease studies recruiting or about to start — once a week, free: studies that open, close, add sites or post results.

Watch these studies
See an example email

Example · made-up studies

Breast cancer · Recruiting: 2 came in, 3 changed

What changed in your saved searches, Oct 31 – Nov 6:

A study of drug A after surgery for early breast cancer

Came in · now Recruiting

Drug B with hormone therapy in advanced breast cancer

Changed

· Sites: 4 added, including Seoul and Busan

· Enrollment: 300 → 450 participants

Exercise during chemotherapy

Now Active, not recruiting

One email a week for all your saved searches. Stop any time.

Status

Recruiting
28
Completed
12
Status unknown
12
Not yet recruiting
11
Active, not recruiting
6
Terminated
1

Phase

Phase 2
17
Phase 3
8
Early Phase 1
8
Phase 1
5
Phase 4
3

Where

China
40
United States
14
Spain
7
Israel
6
Italy
6
France
6

Who runs them

Peking Union Medical College Hospital (14) · Meir Medical Center (4) · Chinese PLA General Hospital (3) · Wen Zhang (3) · Tongji Hospital (3) · Assistance Publique Hopitaux De Marseille (2) · Peking University People's Hospital (2) · Amgen (2)

What is being tested here

Drugs under test in Immunoglobulin G4-Related Disease studies, those with the most open studies first. Medicines only given beside them are not counted. How drugs are counted

DrugOpenPhase 3All
Mycophenolic Acid204
Lenalidomide223
Leflunomide203
Inebilizumab112
Rilzabrutinib112
Tripterygium wilfordii101
Amulirafusp alfa111
Sirolimus101
Imiquimod101
YTS109101

Drug classes tested here Tyrosine kinase inhibitors (TKIs) 3 open · JAK inhibitors 2 open

Coming up

7phase 3 studies under way
11studies finish main data collection within a year

Studies recruiting or running, from their records. “Main data collection” ends at the primary completion date, the sponsor’s own estimate, which often moves.

The 10 nearest

Who these studies take

Of the 28 Immunoglobulin G4-Related Disease studies recruiting now, 12 (43%) set no upper age limit and 13 (46%) stop at 75 or younger. 3 (11%) take children under 18. 0 (0%) are for women only and 1 (4%) for men only; 3 (11%) take healthy volunteers.

Recruiting studies that take each age, of 28
AgeWomenMen
103 (11%)3 (11%)
1827 (96%)27 (96%)
3026 (93%)26 (93%)
4026 (93%)26 (93%)
5026 (93%)27 (96%)
6526 (93%)27 (96%)
7521 (75%)22 (79%)
8512 (43%)13 (46%)

Across all 72 studies, recruiting or not: 40% stop at 75 or younger and 10% at 65; 6% take children; 0% are for women only and 1% for men only; 13% take healthy volunteers. From each study’s registry entry; the criteria on its page decide.

What changed recently

From the registry's own updates since Oct 15, 2026.

Started recruiting1

Newly registered3

Studies

Recruiting first, then most recently updated. Showing 50 of 72. Browse all 72 → or search them.